alnylam pharmaceuticals inc
(ALNY:Consolidated Issue Listed on NASDAQ Global Select )
Victor Kotelianski M.D., Ph.D.
Former Senior Vice President of Distinguished Alnylam Fellow and Member of Scientific Advisory Board, Alnylam Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
Dr. Victor E. Kotelianski, MD, PhD, has been Senior Vice President of Alnylam Pharmaceuticals Inc. since October 2008. Dr. Kotelianski provides continued support on evaluation and management of external initiatives, including delivery technologies, academic and corporate collaborations, and future spin-out opportunities. He served as Vice President of Research and Development of Alnylam Pharmaceuticals Inc., from April 2003 to August 2008. Dr. Kotelianski has been instrumental ...
300 Third StreetPhone: 617-551-8200
Cambridge, Massachusetts 02142
Board Members Memberships*There is no Board Members Memberships data available.
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Ali Mortazavi||Chief Executive and Director|
Silence Therapeutics plc
|Hans G. C. P. Schikan||Chief Executive Officer and Member of Management Board|
Prosensa Holding N.V.
|Mark W. Schwartz Ph.D.||Chief Executive Officer, President and Director|
Galena Biopharma, Inc.
|Mark J. Murray Ph.D.||Chief Executive Officer, President and Director|
Tekmira Pharmaceuticals Corporation
|Kleanthis G. Xanthopoulos Ph.D.||Chief Executive Officer, President, Principal Financial & Accounting Officer and Director|
Regulus Therapeutics Inc.
|$600.0K||Compensation as of Fiscal Year 2013.|